Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults
…, F Mwimanzi, HR Lapointe, Y Sang… - The Journal of …, 2022 - academic.oup.com
Background The magnitude and durability of immune responses to coronavirus disease
2019 (COVID-19) mRNA vaccines remain incompletely characterized in the elderly. Methods …
2019 (COVID-19) mRNA vaccines remain incompletely characterized in the elderly. Methods …
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
…, F Mwimanzi, HR Lapointe, PK Cheung, Y Sang… - npj Vaccines, 2022 - nature.com
Humoral responses to COVID-19 vaccines in people living with HIV (PLWH) remain
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 spike …
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 spike …
Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine but strong initial responses to a third dose
…, HR Lapointe, PK Cheung, Y Sang… - The Journal of …, 2022 - academic.oup.com
Background Third coronavirus disease 2019 (COVID-19) vaccine doses are broadly
recommended, but immunogenicity data remain limited, particularly in older adults. Methods We …
recommended, but immunogenicity data remain limited, particularly in older adults. Methods We …
[HTML][HTML] People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose …
HR Lapointe, F Mwimanzi, PK Cheung, Y Sang… - medRxiv, 2022 - ncbi.nlm.nih.gov
Background: Longer-term humoral responses to two-dose COVID-19 vaccines remain
incompletely characterized in people living with HIV (PLWH), as do initial responses to a third …
incompletely characterized in people living with HIV (PLWH), as do initial responses to a third …
People with human immunodeficiency virus receiving suppressive antiretroviral therapy show typical antibody durability after dual coronavirus disease 2019 …
…, F Mwimanzi, PK Cheung, Y Sang… - The Journal of …, 2023 - academic.oup.com
Background Longer-term humoral responses to 2-dose coronavirus disease 2019 (COVID-19)
vaccines remain incompletely characterized in people living with human …
vaccines remain incompletely characterized in people living with human …
Viral proteins with PxxP and PY motifs may play a role in multiple sclerosis
KS Pi, Y Sang, SK Straus - Viruses, 2022 - mdpi.com
Multiple sclerosis (MS) is a debilitating disease that arises from immune system attacks to
the protective myelin sheath that covers nerve fibers and ensures optimal communication …
the protective myelin sheath that covers nerve fibers and ensures optimal communication …
Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy
HR Lapointe, F Mwimanzi, PK Cheung, Y Sang… - Aids, 2023 - journals.lww.com
Background: Limited data exist regarding longer term antibody responses following three-dose
coronavirus disease 2019 (COVID-19) vaccination, and the impact of a first SARS-CoV-2 …
coronavirus disease 2019 (COVID-19) vaccination, and the impact of a first SARS-CoV-2 …
[HTML][HTML] Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine
MA Brockman, F Mwimanzi, Y Sang, K Ng, O Agafitei… - medRxiv, 2021 - ncbi.nlm.nih.gov
Background. Several Canadian provinces are extending the interval between COVID-19
vaccine doses to increase population vaccine coverage more rapidly. However, …
vaccine doses to increase population vaccine coverage more rapidly. However, …
SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive antiretroviral therapy
PK Cheung, HR Lapointe, Y Sang, S Ennis… - Aids, 2023 - journals.lww.com
Objective: Limited data exist regarding the immune benefits of fourth COVID-19 vaccine doses
in people with HIV (PWH) receiving antiretroviral therapy (ART), particularly now that most …
in people with HIV (PWH) receiving antiretroviral therapy (ART), particularly now that most …
Serial infection with SARS-CoV-2 Omicron BA. 1 and BA. 2 following three-dose COVID-19 vaccination
HR Lapointe, F Mwimanzi, PK Cheung, Y Sang… - Frontiers in …, 2022 - frontiersin.org
SARS-CoV-2 Omicron infections are common among individuals who are vaccinated or
have recovered from prior variant infection, but few reports have immunologically assessed …
have recovered from prior variant infection, but few reports have immunologically assessed …
